Safety and effectiveness of long-acting versus intermediate-acting insulin for patients with type 1 diabetes: a systematic review and individual patient data network meta-analysis (IPD-NMA)
[sidebar]
Commissioned and Funded by: Canadian Institutes of Health Research (CIHR)
Share Buttons [span][/span]
[ssba-buttons] [/sidebar] [sidebar-content]- Aims to evaluate the comparative safety and effectiveness of long-acting insulin analogues (detemir/glargine) versus intermediate-acting (NPH and lente) and long-acting insulin in different subgroups of patients with type 1 diabetes
- The individual patient data network meta-analysis (IPD NMA) results of this study will provide tailored evidence to improve existing guideline recommendations and inform decision-makers (e.g., the American and Canadian Diabetes Association, and the European Association for the Study of Diabetes) about the safety and effectiveness of these interventions
Related Projects:
[/sidebar-content]Category : KS Projects
Date : 21 Aug 2020